1. Tsuji K, Tsutani K. Approval of new drugs 1999–2007: comparison of the US, the EU and Japan situations. J Clin Pharm Ther. 2010;35(3):289–301.
2. Ministry of Health, Labour and Welfare. Ethnic factors in the acceptability of foreign clinical data. (in Japanese) 1998.
https://www.pmda.go.jp/files/000156571.pdf
Accessed 15 Aug 2018.
3. Ministry of Health, Labour and Welfare. Guidance for establishing safety in first-in-human studies during drug development. 2005.
https://www.pmda.go.jp/files/000208201.pdf
Accessed 15 Aug 2018.
4. Ministry of Health, Labour and Welfare. Basic principles on global clinical trials. 2007.
https://www.pmda.go.jp/files/000157900.pdf
Accessed 15 Aug 2018.
5. Ito Y, Narimatsu H, Fukui T, Fukao A, Yoshioka T. Critical review of ‘Public domain application’: a flexible drug approval system in Japan. Ann Oncol. 2013;24(5):1297–305.